# Mean Visual Acuity Changes Following Five Injections of Aflibercept

> **NCT02645266** · NA · ACTIVE_NOT_RECRUITING · sponsor: **McMaster University** · enrollment: 48 (estimated)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Aflibercept Injection [Eylea]

## Key facts

- **NCT ID:** NCT02645266
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-05-01
- **Primary completion:** 2025-09
- **Final completion:** 2025-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02645266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02645266, "Mean Visual Acuity Changes Following Five Injections of Aflibercept". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02645266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*